
    
      This is a prospective, open-label, multi-centre, interventional, medical device,
      post-marketing study. Each subject will act as his/her own control. Eligible subjects will
      undergo treatment with Juvéderm® VOLIFT™ with Lidocaine injected into the lips for lip
      augmentation.
    
  